HOME >> MEDICINE >> NEWS
Tuberculosis drug combined with virtual reality therapy is effective in treating fear of heights

A tuberculosis drug called D-cycloserine (DCS), used in concert with psychotherapy, is an effective treatment for some anxiety-related disorders, according to research by scientists at Emory University School of Medicine and the Center for Behavioral Neuroscience (CBN). The study was led by Michael Davis, PhD, Kerry Ressler, MD, PhD, and Barbara Rothbaum, PhD, of the Department of Psychiatry and Behavioral Sciences and is reported in the November issue of the Archives of General Psychiatry.

In the study of 28 people suffering from acrophobia, which is an abnormal fear of heights, either DCS or placebo was given to study participants, followed by two virtual reality sessions that simulated standing in a rising glass elevator. Compared to subjects who took only placebo, those treated with DCS experienced a significant reduction in their fear of heights that was maintained for at least three months (the longest time tested) after concluding therapy.

The mechanisms governing the fear response, located in a region of the brain called the amygdala, function abnormally in an acrophobic's brain. DCS binds to neurotransmitter receptors in the amygdala called NMDA (N-methyl-D-aspartate) receptors. When combined with virtual reality exposure therapy, DCS facilitates fear extinction in the acrophobic's brain.

"Cognitive behavioral psychotherapy uses a process called 'fear extinction' to treat individuals with phobias, as well as more complicated problems, such as post-traumatic stress syndrome," said Dr. Davis.

"Fear extinction involves repeated exposure to a fearful memory or object, in the absence of adverse consequences. Because it was known that DCS improves NMDA synaptic transmission and we found it improved extinction in rats, we hoped to facilitate the effects of cognitive behavioral therapy by combining DCS with virtual reality therapy in humans. Our results demonstrate that this combination is effective, and that these effects can be long lasti
'"/>

Contact: Kathi Baker
kobaker@emory.edu
404-727-9371
Emory University Health Sciences Center
5-Nov-2004


Page: 1 2

Related medicine news :

1. Tuberculosis strains stay close to home, say Stanford researchers
2. UCSD Medical Center receives NIH contract to set up National Tuberculosis Educational Curriculum
3. Tuberculosis Foundation selects Core Research Scientists
4. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
5. Detrol LA combined with standard treatment for enlarged prostate is twice as effective
6. Nicotine more addictive when combined with other tobacco smoke chemicals, UCI study finds
7. Cognitive behavioral therapy combined with antidepressant effective in treating adolescent OCD
8. Heart disease kills more women annually than all cancers combined
9. Stents combined with clot-busting drugs effective in limiting impact of deadly form of stroke
10. Study shows people with Alzheimers can benefit from exercise combined with caregiver training
11. Wyeth chemists honored for Prevnar first combined pneumococcal vaccine for infants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... , ... In the past, one of the first steps of a FUE ... reason many patients did not have a hair transplant. According to Dr. Parsa Mohebi, ... get the hairline they desire without shaving their head. This method was initially introduced ...
(Date:2/19/2019)... ... 19, 2019 , ... Conducting Advanced Root Cause Analysis CAPA ... FDAnews and Learning Plus**, Mar. 26-27, 2019 – Princeton, NJ, http://www.fdanews.com/capapc ... Feb. 26. , The greatest threat to compliance is ... overconfidence. , ...
(Date:2/19/2019)... ... February 19, 2019 , ... The American ... (CMAC). Originally developed and launched by the Center for Case Management in 2000, ... management administrators, managers, supervisors and leaders. , “I created the CMAC credential ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... Wachler, MD, has launched the first ever supplement to help support Keratoconus cornea ... to severe vision loss. The supplement, KC Defense, includes specific amounts Copper (Cu) ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... WEDI ... efficiencies in healthcare information exchange and a statutory advisor to the U.S. Department of ... President and CEO, Charles Stellar. The statement was issued following the release last week ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... ... February 19, 2019 , ... As one of Delaware’s most-esteemed living artists, fine-arts painter ... in the morning to paint, it’s not work,” he said. “You get that feeling in ... SHARING SERENITY AND FULFILLMENT, Fine art has also given the former commercial artist a serenity ...
(Date:2/19/2019)... ... February 19, 2019 , ... Leading podiatrists in Miami, FL, ... pedicure services with their newest venture, Medicure Hand and Foot Spa. Medicure offers ... from Diabetes and Arthritis, and those undergoing Chemotherapy. , Preventing the many risks ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... Syndrome by providing the scientific community with additional opportunities to further research into ... Chief Scientific Officer of the Foundation’s Scientific Advisory Board and the addition of ...
Breaking Medicine Technology:
Cached News: